SLGL Sol-Gel Technologies Ltd. - Ordinary Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 19, 2026
$72.00
· of 52w range
· above low
· to high
$28.5052w low
$97.9752w high
Market Cap
$201M
P/E
-32.9
EPS
$-2.19
Revenue
$19M
your badges
52W Range
$28–$98
Analyst Rating
BUY
Price Target
$152
P/E
-32.9
ROE
-23.7%
Net Profit Margin
-31.6%
Your badge strip is empty — pin a metric anywhere on this page.
SLGL Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$72.00
Market Cap
$201M
P/E
-32.9
EPS
$-2.19
Revenue
$19M
ROE
-23.7%
52W Range
$29–$98
SLGL Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| May 5, 2025 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$19M2017-12-31 → 2025-12-31
EPS$-2.192019-12-31 → 2025-12-31
Free Cash Flow$275.0K2017-12-31 → 2025-12-31
Net margin-31.6%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | SLGL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -32.95Y avg ≈87.1 | ≈87.1 | · | · | |
| P/S | 10.35Y avg ≈110.6 | ≈110.6 | · | · | |
| P/B | 8.85Y avg ≈15.6 | ≈15.6 | · | · | |
| Price / FCF | 729.45Y avg ≈12.7 | ≈12.7 | · | · | |
| Price / Cash Flow | 622.95Y avg ≈-1.0 | ≈-1.0 | · | · | |
| Price / Tangible Book | 8.85Y avg ≈15.6 | ≈15.6 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | SLGL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin | -38.9%5Y avg ≈-487.5% | ≈-487.5% | · | · | |
| EBITDA Margin | -38.9%5Y avg ≈-487.5% | ≈-487.5% | · | · | |
| Net Profit Margin | -31.6%5Y avg ≈-450.0% | ≈-450.0% | · | · | |
| ROA | -18.6%5Y avg ≈-24.9% | ≈-24.9% | · | · | |
| ROE | -23.7%5Y avg ≈-29.4% | ≈-29.4% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | SLGL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 4.45Y avg ≈7.4 | ≈7.4 | · | · | |
| Quick Ratio | 4.25Y avg ≈5.5 | ≈5.5 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | SLGL | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.3 | ≈0.3 | · | · | |
| Receivables Turnover | 7.05Y avg ≈4.9 | ≈4.9 | · | · | |
| Revenue / Employee | ≈$692.4K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-15.7%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 20, 2026 | $-1.13 | $-2.36 | 52.0% |
| March 31, 2026 | May 28, 2026 | $-1.31 | $-1.88 | 30.2% |
| Dec. 31, 2025 | $-1.07 | $0.40 | -369.0% | |
| Sept. 30, 2025 | $-2.13 | $-2.13 | 0.08% | |
| Sept. 30, 2024 | $-0.10 | $-1.33 | 92.5% | |
| June 30, 2024 | $0.70 | $-2.04 | 134.3% | |
| March 31, 2024 | $-2.30 | $-1.53 | -50.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $19M | $12M | $2M | $4M | $31M | $9M | $23M | $129.0K | $174.0K | |
| R&D Expense | $23M | $18M | $24M | $13M | $20M | $28M | $41M | $28M | $26M | |
| SG&A Expense | $4M | $6M | $7M | $7M | $8M | $11M | $8M | $6M | $6M | |
| Operating Income | $-8M | $-12M | $-29M | $-16M | $3M | $-30M | $-26M | $-34M | $-32M | |
| Pretax Income | · | · | · | · | $3M | $-29M | $-25M | $-33M | $-32M | |
| Income Tax | $0 | $0 | $0 | · | $0 | $0 | $33.0K | · | · | |
| Net Income | $-6M | $-11M | $-27M | $-15M | $3M | $-29M | $-25M | $-32M | $-32M | |
| EPS (Basic) | $-2.19 | $-3.79 | $-10.01 | $-0.65 | $0.14 | $-1.30 | $-1.26 | · | · | |
| EPS (Diluted) | $-2.19 | $-3.79 | $-10.01 | $-0.65 | $0.14 | $-1.30 | $-1.26 | · | · | |
| Shares (Basic) | 2,785,875 | 2,785,787 | 2,708,708 | 23,128,722 | 23,063,493 | 22,574,688 | 19,534,562 | · | · | |
| Shares (Diluted) | 2,785,875 | 2,785,787 | 2,708,708 | 23,128,722 | 23,566,182 | 22,574,688 | 19,534,562 | · | · | |
| EBITDA | $-8M | $-12M | $-29M | $-16M | $3M | · | $-26M | $-34M | $-32M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $19M | $8M | $12M | $20M | $7M | $9M | $5M | $5M | |
| Short-term Investments | $13M | $4M | $20M | $9M | $2M | $22M | $41M | $57M | · | |
| Receivables | $2M | $4M | $377.0K | $62.0K | $13M | $2M | $4M | · | · | |
| Prepaid Expense | $1M | $4M | $3M | $2M | $800.0K | $1M | $1M | $3M | $2M | |
| Current Assets | $27M | $31M | $41M | $43M | $57M | $53M | $56M | $66M | $11M | |
| PP&E (Net) | $140.0K | $202.0K | $434.0K | $660.0K | $1M | $2M | $2M | $3M | $2M | |
| PP&E (Gross) | $4M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $4M | |
| Accum. Depreciation | $4M | $6M | $6M | $6M | $5M | $5M | $4M | $3M | $2M | |
| Other Non-current Assets | $62.0K | $13.0K | $55.0K | · | · | · | · | · | · | |
| Total Assets | $30M | $36M | $45M | $47M | $69M | $59M | $61M | $70M | $15M | |
| Accounts Payable | · | · | · | · | $766.0K | $1M | $2M | $3M | $534.0K | |
| Accrued Liabilities | $3M | $1M | $2M | $1M | $2M | $3M | $3M | $1M | $910.0K | |
| Short-term Debt | · | · | · | · | · | · | · | · | $65M | |
| Current Liabilities | $6M | $5M | $5M | $3M | $12M | $6M | $7M | $5M | $67M | |
| Capital Leases | $496.0K | $878.0K | $1M | $54.0K | $810.0K | $1M | $1M | · | · | |
| Total Liabilities | $7M | $7M | $7M | $4M | $14M | $8M | $9M | $6M | $68M | |
| Total Debt | · | · | · | · | · | · | · | · | $65M | |
| Common Stock | $774.0K | $774.0K | $774.0K | $638.0K | $638.0K | $635.0K | $561.0K | $520.0K | $82.0K | |
| Retained Earnings | $-237M | $-231M | $-220M | $-193M | $-178M | $-181M | $-152M | $-127M | $-95M | |
| Stockholders' Equity | $23M | $29M | $39M | $42M | $56M | $51M | $52M | $64M | $-53M | |
| Liabilities + Equity | $30M | $36M | $45M | $47M | $69M | $59M | $61M | $70M | $15M | |
| Shares Outstanding | 2,785,787 | 2,786,158 | 2,785,787 | 2,312,972 | 23,126,804 | 23,000,782 | 20,402,800 | 18,949,968 | 6,290,244 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $109.0K | $233.0K | $342.0K | $562.0K | $880.0K | $946.0K | $887.0K | $762.0K | $471.0K | |
| Stock-based Comp | $82.0K | $786.0K | $2M | $2M | $687.0K | $1M | $3M | $5M | $4M | |
| Operating Cash Flow | $322.0K | $-14M | $-18M | $-9M | $-8M | $-25M | $-22M | $-23M | $-24M | |
| CapEx | $47.0K | $2.0K | $134.0K | $171.0K | $143.0K | $449.0K | $597.0K | $1M | $2M | |
| Investing Cash Flow | $-9M | $27M | $-10M | $2M | $20M | $-3M | $16M | $-55M | $-6M | |
| Financing Cash Flow | $6.0K | $0 | $22M | $15.0K | $837.0K | $26M | $11M | $79M | $28M | |
| Net Change in Cash | $-8M | $13M | $-6M | $-8M | $13M | $-1M | $4M | $651.0K | $-2M | |
| Taxes Paid | · | · | $0 | $0 | $34.0K | $7.0K | $0 | · | · | |
| Free Cash Flow | $275.0K | $-14M | $-18M | $-10M | $-8M | · | $-23M | $-25M | $-26M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -38.9% | -104.1% | -1885.8% | -418.3% | 9.5% | · | -113.3% | -25985.3% | -18179.9% | |
| Net Margin | -31.6% | -91.7% | -1752.8% | -384.3% | 10.3% | · | -107.4% | -24963.6% | -18142.5% | |
| Pretax Margin | · | · | · | · | 10.3% | · | -107.3% | · | · | |
| EBITDA Margin | -38.9% | -104.1% | -1885.8% | -418.3% | 9.5% | · | -113.3% | -25985.3% | -18179.9% | |
| ROA | -18.6% | -26.1% | -59.3% | -25.8% | 5.0% | · | -37.6% | -75.8% | -240.1% | |
| ROE | -23.7% | -31.4% | -67.4% | -30.5% | 6.0% | · | -42.3% | -574.5% | 75.1% | |
| ROIC | · | · | · | · | 5.3% | · | -49.5% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.4 | 5.9 | 9.1 | 12.9 | 4.9 | · | 8.6 | 13.5 | 0.2 | |
| Quick Ratio | 4.2 | 5.2 | 6.3 | 8.7 | 3.0 | · | 8.4 | 12.7 | 0.1 | |
| Debt / Equity | · | · | · | · | · | · | · | · | -1.2 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.3 | 0.0 | 0.1 | 0.5 | · | 0.3 | 0.0 | 0.0 | |
| Receivables Turnover | 7.0 | 5.8 | 7.1 | 0.4 | 4.1 | · | 11.1 | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.19 | $1.04 | $1.39 | $1.83 | $2.40 | · | $2.57 | $3.37 | $-8.38 | |
| Revenue / Share | $6.96 | $0.41 | $0.06 | $0.17 | $1.33 | · | · | · | · | |
| Cash Flow / Share | $0.12 | $-0.50 | $-0.65 | $-0.41 | $-0.33 | · | · | · | · | |
| Cash / Share | $3.96 | $0.70 | $0.27 | $0.54 | $0.87 | · | $0.46 | $0.28 | $0.80 | |
| EPS (TTM) | $-2.19 | $-3.79 | $-10.01 | $-0.65 | $0.14 | · | $-1.26 | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $19M | $12M | $2M | $4M | $31M | · | $23M | $129.0K | $174.0K | |
| Net Income TTM | $-6M | $-11M | $-27M | $-15M | $3M | · | $-25M | $-32M | $-32M | |
| Market Cap | $117M | $259M | $308M | $1.05B | $1.71B | · | $3.50B | $1.14B | · | |
| P/E | -19.2 | -2.5 | -1.1 | -70.2 | 528.6 | · | -136.1 | · | · | |
| P/S | 6.1 | 22.5 | 198.1 | 271.6 | 54.7 | · | 152.8 | 8843.3 | · | |
| P/B | 5.1 | 9.0 | 8.0 | 25.0 | 30.8 | · | 66.7 | 17.9 | · | |
| P / Tangible Book | 5.1 | 9.0 | 8.0 | 25.0 | 30.8 | · | · | · | · | |
| P / Cash Flow | 364.6 | -18.7 | -17.4 | -111.2 | -222.5 | · | -155.5 | -48.6 | · | |
| P / FCF | 426.9 | -18.7 | -17.2 | -109.2 | -218.5 | · | -151.5 | -46.5 | · | |
| Earnings Yield | -5.2% | -40.8% | -90.6% | -1.4% | 0.19% | · | -0.73% | · | · |
Per Share
| Metric | Trend | Q4 2020 |
|---|---|---|
| EPS (TTM) | $-1.30 |
Valuation (TTM)
| Metric | Trend | Q4 2020 |
|---|---|---|
| Revenue TTM | $9M | |
| Net Income TTM | $-29M | |
| P/E | -75.3 | |
| Earnings Yield | -1.3% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $19M | $12M | $2M | $4M | $31M |
| Operating Margin % | -38.9% | -104.1% | -1885.8% | -418.3% | 9.5% |
| Net Income | $-6M | $-11M | $-27M | $-15M | $3M |
| Diluted EPS | $-2.19 | $-3.79 | $-10.01 | $-0.65 | $0.14 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 4.4 | 5.9 | 9.1 | 12.9 | 4.9 |
| Quick Ratio | 4.2 | 5.2 | 6.3 | 8.7 | 3.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $275.0K | $-14M | $-18M | $-10M | $-8M |
Institutional owners (13F) 24 filers · $97.7M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
24
Value held
$97.7M
New positions
5
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 5 (-4 vs prior Q) | 2 (0 vs prior Q) | 6 (+2 vs prior Q) | 7 (+4 vs prior Q) | +62K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Opaleye Management Inc. | $37,070,000 | 500,000 | 37.95% | Shares |
| GREAT POINT PARTNERS LLC | $20,341,273 | 274,363 | 20.82% | Shares |
| Phoenix Financial Ltd. | $10,835,316 | 146,147 | 11.09% | Shares |
| Trails Edge Capital Partners, LP | $10,338,452 | 139,445 | 10.58% | Shares |
| Affinity Asset Advisors, LLC | $6,294,486 | 84,900 | 6.44% | Shares |
| Squadron Capital Management LLC | $3,855,280 | 52,000 | 3.95% | Shares |
| CITADEL ADVISORS LLC | $2,413,702 | 32,556 | 2.47% | Shares |
| GILDER GAGNON HOWE & CO LLC | $1,668,150 | 22,500 | 1.71% | Shares |
| Stonepine Capital Management, LLC | $1,072,732 | 14,469 | 1.10% | Shares |
| Yelin Lapidot Holdings Management Ltd. | $769,870 | 10,384 | 0.79% | Shares |
| JANE STREET GROUP, LLC | $619,588 | 8,357 | 0.63% | Shares |
| MENORA MIVTACHIM HOLDINGS LTD. | $564,280 | 7,611 | 0.58% | Shares |
| NAVELLIER & ASSOCIATES INC | $428,900 | 5,785 | 0.44% | Shares |
| MORGAN STANLEY | $341,563 | 4,607 | 0.35% | Shares |
| LPL Financial LLC | $289,443 | 3,904 | 0.30% | Shares |
| MILLENNIUM MANAGEMENT LLC | $247,776 | 3,342 | 0.25% | Shares |
| XTX Topco Ltd | $220,492 | 2,974 | 0.23% | Shares |
| TWO SIGMA SECURITIES, LLC | $200,771 | 2,708 | 0.21% | Shares |
| BlackRock, Inc. | $70,655 | 953 | 0.07% | Shares |
| UBS Group AG | $30,842 | 416 | 0.03% | Shares |
| Tower Research Capital LLC (TRC) | $7,414 | 100 | 0.01% | Shares |
| SBI Securities Co., Ltd. | $5,338 | 72 | 0.01% | Shares |
| HRT FINANCIAL LP | $463 | 6,256 | 0.00% | Shares |
| Allworth Financial LP | $371 | 5 | 0.00% | Shares |
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Moshe Arkin, M. Arkin Dermatology Ltd. ×3 filings | April 15, 2026 | 56.60% | Amendment | · | SEC |
| M. Arkin Dermatology Ltd., Moshe Arkin ×5 filings | April 8, 2024 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 1 insider · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% owner | Sept. 11, 2026 P | 540,000 | 49 | 0 | $11,226,017 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0.56% | 1,736 SH | Oct. 1, 2026 | Daily |
SLGL Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 10 analysts
BUY
Median target
$152.50
+111.8%
2 20.0%
Strong Buy
7 70.0%
Buy
1 10.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
2 analysts · 2026-09-29Mean target $152.50 +111.8%
← Below all targets
Current price $72.00
Low$110.00
Mean$152.50
High$195.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 19, 2026